New & Noteworthy

Submit New & Noteworthy

March 2020

Immunoglobulin Treatment

Grifols

Grifols presents XEMBIFY (immune globulin subcutaneous human-klhw), a 20% subcutaneous immunoglobulin (IG) for the treatment of primary immunodeficiency diseases. With maximum immunoglobulin G (IgG) potency and purity due to the unique caprylate/chromatography process, XEMBIFY provides a customizable IG treatment option (from weekly to daily) to offer protection from infections.

Grifols

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: